Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.

Phase 3 Completed 267 enrolled Astellas Pharma Inc Astellas Pharma Europe B.V. · collab

RandomizedParallel-groupOpen-labelPrevention

Summary

Primary objective of this study is to compare the renal function as well as the incidence of renal dysfunction, the incidence of death, graft loss and acute rejection. Secondary Objective is to compare the efficacy and safety profiles of the two regimens in elderly renal transplanted patients.

Timeline

Start: 2004-10
Primary completion: 2006-08
Completion: 2006-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Tacrolimus	Small molecule	—	—

Indications

No indication recorded.